E. ÖZKAN Et Al. , "Decreased Tc-99m sestamibi uptake in a sternal brown tumor indicating response to anti metabolic therapy for secondary hyperparathyroidism," CLINICAL NUCLEAR MEDICINE , vol.32, no.8, pp.661-662, 2007
ÖZKAN, E. Et Al. 2007. Decreased Tc-99m sestamibi uptake in a sternal brown tumor indicating response to anti metabolic therapy for secondary hyperparathyroidism. CLINICAL NUCLEAR MEDICINE , vol.32, no.8 , 661-662.
ÖZKAN, E., Arslan, N., Arslanoglu, A., & Karacalioglu, A. O., (2007). Decreased Tc-99m sestamibi uptake in a sternal brown tumor indicating response to anti metabolic therapy for secondary hyperparathyroidism. CLINICAL NUCLEAR MEDICINE , vol.32, no.8, 661-662.
ÖZKAN, ELGİN Et Al. "Decreased Tc-99m sestamibi uptake in a sternal brown tumor indicating response to anti metabolic therapy for secondary hyperparathyroidism," CLINICAL NUCLEAR MEDICINE , vol.32, no.8, 661-662, 2007
ÖZKAN, ELGİN Et Al. "Decreased Tc-99m sestamibi uptake in a sternal brown tumor indicating response to anti metabolic therapy for secondary hyperparathyroidism." CLINICAL NUCLEAR MEDICINE , vol.32, no.8, pp.661-662, 2007
ÖZKAN, E. Et Al. (2007) . "Decreased Tc-99m sestamibi uptake in a sternal brown tumor indicating response to anti metabolic therapy for secondary hyperparathyroidism." CLINICAL NUCLEAR MEDICINE , vol.32, no.8, pp.661-662.
@article{article, author={ELGİN ÖZKAN Et Al. }, title={Decreased Tc-99m sestamibi uptake in a sternal brown tumor indicating response to anti metabolic therapy for secondary hyperparathyroidism}, journal={CLINICAL NUCLEAR MEDICINE}, year=2007, pages={661-662} }